Agenda
Times listed are for Eastern Daylight Savings Time.
Download a PDF version of the agenda.
Day 1 (10:50 AM to 5:30 PM)
10:50-11:00 AM |
Welcome Altaf Mohammed, Ph.D., Meeting Co-Organizer, DCP/NCI Mark Miller, Ph.D., Meeting Co-Organizer, DCP/NCI |
11:00-12:00 PM |
Plenary Talk Steven Lipkin, M.D., Ph.D., Weill Cornell Medicine The CAP-IT Center for LNP RNA Immunoprevention |
Session I: Molecularly Targeted Novel Agents and Emerging Technologies for Preventative Agent Development Research | |
---|---|
Co-Chairs: Margie Clapper, Ph.D. and John Clifford, Ph.D. | |
12:00-12:30 PM |
Speaker 1: Margie Clapper, Ph.D., Fox Chase Cancer Center Modulation of Estrogen Metabolism as a Strategy for the Early Interception of Non-Small Cell Lung Cancer |
12:30-1:00 PM |
Speaker 2: Chinthalapally V. Rao, Ph.D., Oklahoma University Health Sciences Center Interception of CRC Progression in FAP Rat Model Using a Combinational Targeting of TRAIL Signaling and Inflammation |
1:00-1:30 PM |
Lunch |
1:30-2:00 PM |
Speaker 3: Fan Zhang, Ph.D., College of Pharmacy, University of Florida Health Tuning the Organ-Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles |
2:00-2:30 PM |
Speaker 4: Pratip Bhattacharya, Ph.D., MD Anderson Cancer Center Real-time Hyperpolarized Metabolic Imaging for Early Detection and Prevention of Pancreatic Cancer |
2:30-3:00 PM |
Speaker 5: Pankaj Singh, Ph.D., OU Health Stephenson Cancer Center |
3:00-3:30 PM |
Break |
3:30-4:30 PM |
Early Investigator Flash Talks Co-Chairs: Altaf Mohammed, Ph.D. and Mark Miller, Ph.D. |
3:30-3:45 PM |
Speaker 1: Atieh Hajirahimkhan, Ph.D., Northwestern University |
3:45-4:00 PM |
Speaker 2: Surya Singh, Ph.D., Oklahoma University Health Sciences Center |
4:00-4:15 PM |
Speaker 3: Mariana Bustamante Eduardo, Ph.D., Feinberg School of Medicine |
4:15-4:30 PM |
Speaker 4: Tomonori Oka, M.D. Ph.D., Harvard Medical School |
4:30-5:30 PM |
Meet with the NCI Program Staff Session, Moderator: Goli Samimi, Ph.D., M.P.H
|
Adjourn |
Day 2 Sessions (11:00 AM to 4:00 PM)
Session II: Emerging Vaccines and Immunomodulatory Agents for Cancer Prevention | |
---|---|
Co-Chairs: Catherine J. Wu, M.D. and Shizuko Sei, M.D. | |
11:00-11:30 AM |
Speaker 1: Catherine J. Wu, M.D., Dana Farber Cancer Institute Updates on Personalized Cancer Vaccines |
11:30-12:00 PM |
Speaker 2: Madhav Dhodapkar, M.B.S.S, Emory University Targeting Underlying Triggers and Spatial Immunology Towards Cancer Prevention |
12:00-12:30 PM |
Speaker 3: Vinod P. Balachandran, M.D., Memorial Sloan Kettering Cancer Center Personalized RNA Vaccines for Pancreatic Cancer |
12:30-1:00 PM |
Speaker 4: Steven Reed, Ph.D., HDTBio RNA Vaccines for Cancer: Overcoming Challenges |
1:00-1:30 PM |
Speaker 5: Barbara Vanderhyden, Ph.D., University of Ottawa Targeting Age-Associated Ovarian Fibrosis to Reduce Cancer Risk |
1:30-2:00 PM | Lunch |
Session III: NCI Resources Session | |
Co-Chair: Mark Miller, Ph.D. | |
2:00-2:30 PM |
Altaf Mohammed, Ph.D., Program Director, DCP/NCI CIP-Net Cooperative Grant Program |
2:30-3:00 PM |
Vignesh Gunasekharan, Ph.D., Deputy Director of PREVENT Operations, DCP/NCI PREVENT Agent Development Pipeline |
3:00-4:00 PM |
Meet the Expert Session:
|
Adjourn |
Day 3 Session (11:00 AM to 2:30 PM)
Session IV: Navigating Prevention Trials: Challenges and Opportunities | |
---|---|
Co-Chairs: Ajay Bansal, M.D. and Howard Parnes, M.D. | |
11:00-11:30 AM |
Speaker 1: Eva Szabo, M.D., DCP/NCI Overview of DCP Supported Clinical Trials |
11:30-12:00 PM |
Speaker 2: Shadmehr Demehri, M.D., Ph.D., Massachusetts General Hospital Topical Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients |
12:00-12:30 PM |
Speaker 3: Ajay Bansal, M.D., University of Kansas Multivalent Vaccines boosted by IL-15 Superagonist for Cancer Interception in Lynch Syndrome: A Phase IIb Trial |
12:30-1:00 PM |
Lunch |
1:00-1:30 PM |
Speaker 4: Julie Bauman, M.D., M.P.H., George Washington University Cancer Center Green Chemoprevention of Environmental Carcinogenesis: Lessons From The Field |
1:30-2:00 PM |
Speaker 5: Adetunji T. Toriola, M.D., Ph.D., MPH, University of Washington at St. Louis Targeting RANKL Signaling in Premenopausal Women with Dense Breasts |
2:00-2:30 PM |
Speaker 6: Peter Allen, M.D., Duke University Progress Report on the Prevention of Progression to Pancreatic Cancer (3P-C) Trial |
Closing Remarks and Adjourn Altaf Mohammed, Ph.D., Meeting Co-Organizer, DCP/NCI Mark Miller, Ph.D., Meeting Co-Organizer, DCP/NCI |